Skip to main content

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.

Publication ,  Journal Article
Hadigan, C; Meigs, JB; Corcoran, C; Rietschel, P; Piecuch, S; Basgoz, N; Davis, B; Sax, P; Stanley, T; Wilson, PW; D'Agostino, RB; Grinspoon, S
Published in: Clin Infect Dis
January 2001

We evaluated metabolic and clinical features of 71 HIV-infected patients with lipodystrophy by comparing them with 213 healthy control subjects, matched for age and body mass index, from the Framingham Offspring Study. Thirty HIV-infected patients without fat redistribution were compared separately with 90 matched control subjects from the Framingham Offspring Study. Fasting glucose, insulin, and lipid levels; glucose and insulin response to standard oral glucose challenge; and anthropometric measurements were determined. HIV-infected patients with lipodystrophy demonstrated significantly increased waist-to-hip ratios, fasting insulin levels, and diastolic blood pressure compared with controls. Patients with lipodystrophy were more likely to have impaired glucose tolerance, diabetes, hypertriglyceridemia, and reduced levels of high-density lipoprotein (HDL) cholesterol than were controls. With the exception of HDL cholesterol level, these risk factors for cardiovascular disease (CVD) were markedly attenuated in patients without lipodystrophy and were not significantly different in comparison with controls. These data demonstrate a metabolic syndrome characterized by profound insulin resistance and hyperlipidemia. CVD risk factors are markedly elevated in HIV-infected patients with fat redistribution.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Infect Dis

DOI

ISSN

1058-4838

Publication Date

January 2001

Volume

32

Issue

1

Start / End Page

130 / 139

Location

United States

Related Subject Headings

  • Risk Factors
  • Middle Aged
  • Microbiology
  • Male
  • Lipodystrophy
  • Lipids
  • Insulin
  • Humans
  • HIV Protease Inhibitors
  • HIV Infections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hadigan, C., Meigs, J. B., Corcoran, C., Rietschel, P., Piecuch, S., Basgoz, N., … Grinspoon, S. (2001). Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis, 32(1), 130–139. https://doi.org/10.1086/317541
Hadigan, C., J. B. Meigs, C. Corcoran, P. Rietschel, S. Piecuch, N. Basgoz, B. Davis, et al. “Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.Clin Infect Dis 32, no. 1 (January 2001): 130–39. https://doi.org/10.1086/317541.
Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001 Jan;32(1):130–9.
Hadigan, C., et al. “Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.Clin Infect Dis, vol. 32, no. 1, Jan. 2001, pp. 130–39. Pubmed, doi:10.1086/317541.
Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, Davis B, Sax P, Stanley T, Wilson PW, D’Agostino RB, Grinspoon S. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001 Jan;32(1):130–139.

Published In

Clin Infect Dis

DOI

ISSN

1058-4838

Publication Date

January 2001

Volume

32

Issue

1

Start / End Page

130 / 139

Location

United States

Related Subject Headings

  • Risk Factors
  • Middle Aged
  • Microbiology
  • Male
  • Lipodystrophy
  • Lipids
  • Insulin
  • Humans
  • HIV Protease Inhibitors
  • HIV Infections